The impact and costs of reimbursed smoking cessation using varenicline in Denmark

J. Dollerup, P. B. Poulsen, P. Tønnesen (Ballerup, Gentofte, Denmark)

Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Dollerup, P. B. Poulsen, P. Tønnesen (Ballerup, Gentofte, Denmark). The impact and costs of reimbursed smoking cessation using varenicline in Denmark. Eur Respir J 2010; 36: Suppl. 54, 5181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Costs and benefits accruing from smoking cessation with varenicline
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Cost-effectiveness of varenicline for smoking cessation in the Netherlands
Source: Eur Respir J 2007; 30: Suppl. 51, 247s
Year: 2007

The cost-effectiveness of smoking cessation interventions. Accounting for medical costs in longer life expectancies
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015

Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015



Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009

How much does smoking cessation (SC) medications impacts on the income of the attendees of a smoking cessation clinic? A cross-sectional study
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016

Does reimbursement increase smoking cessation rate? – Outcomes of ²stop smoking² national program in a smoking cessation center.
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Misjudgements among hospital physicians regarding smoking and smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Smoking habits and the utilization of a smoking cessation service in the UK
Source: Annual Congress 2009 - Smoking cessation
Year: 2009



The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008

The smoking cessation center and three-years impact on smoking among pneumology staff
Source: Annual Congress 2009 - Tobacco and health professionals
Year: 2009

Predicted health and economic benefits of smoking cessation incorporating multiple quit attempts over a lifetime
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011


Efficacy of Zyban as smoking cessation aid for medical staff
Source: Eur Respir J 2001; 18: Suppl. 33, 447s
Year: 2001

Electronic cigarettes knowledge and use among smokers attending an intensive smoking cessation intervention programme
Source: International Congress 2018 – Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes
Year: 2018

How does reimbursement status affect the smoking cessation interventions?
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Half of oral NRT delivered to smoker hospital staff are not use for tobacco cessation but for long term substitution
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013